BWAY
BrainswayCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-23
Current thesis
Primary company releases support real operating momentum: 2025 revenue grew 27% to $52.2 million, profitability improved, 2026 guidance was raised into another 27%-30% growth year, and management is stacking regulatory, reimbursement, and strategic-network initiatives behind the platform [#PR-2026-03-11].
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.4.
What can break
Execution miss versus 2026 guidance after a strong Q4/FY2025 setup
Momentum
68
Value
51
Sentiment
43
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $13.00 · Bull $18.00 · Bear $10.00
Data freshness
Prices
As of 2026-07-23
Fundamentals
As of 2026-07-23 • Vendor: Data Vendor v1
Scores
As of 2026-07-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-23
Investment thesis
As of 2026-07-23
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $17.67
Why
Momentum68 · Δ7d +14.4
Value51 · Δ7d -0.4
Sentiment43 · Δ7d -9.8
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
68
26% active weight
Current posture
7d trendSoftening
Δ7d
+14.4
Δ21d
+20.5
Value
51
39% active weight
Current posture
7d trendFlat
Δ7d
-0.4
Δ21d
-0.1
Sentiment
43
34% active weight
Current posture
7d trendSoftening
Δ7d
-9.8
Δ21d
-9.3
Why this grade
Composite grade C. Momentum 68.1 / Value 51.0 / Sentiment 42.6
Fundamentals (TTM)As of 2026-07-23
Fundamentals (TTM)
As of 2026-07-23
Market Cap
$651.93M
Beta
1.40
Shares Out
40.13M
P/E (TTM)
67.3
P/S (TTM)
8.04
P/FCF (TTM)
21.51
Rev YoY
+35.0%
EPS YoY
+95.2%
Gross Margin
+75.5%
Op Margin
+5.8%
Net Debt
-$62.57M
Current Ratio
3.34
As of 2026-07-23 • Updated nightlySource: Internal modelMethodology